Image de couverture de livre

A User‐Driven Framework for Dose Selection in Pregnancy: Proof of Concept for Sertraline

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Charlotte Koldeweij, Caroline Dibbets, Bryony D. Franklin, Hubertina C. J. Scheepers, Saskia N. de Wildt
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Clinical Pharmacology & Therapeutics
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Machine Learning‐Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents
par: Ethan A. Poweleit, et autres
Publié: (2024)

Optimizing Maternal and Fetal Antibody Exposure and Dosing Regimens During Pregnancy Using a Physiologically Based Pharmacokinetic Model
par: Miramar Sami Kardouh, et autres
Publié: (2025)

Regulatory Interactions and Learnings— RADIAL the Trials@Home Proof‐of‐Concept Trial on Decentralization
par: Helga Gardarsdottir, et autres
Publié: (2025)

Application of Physiologically Based Pharmacokinetic Modeling to Inform Dose Selection of Mezigdomide in a Phase I Drug–Drug Interaction Study
par: Joseph Burnett, et autres
Publié: (2025)

Impact of CYP2C19 Genotype on Sertraline and Escitalopram Exposure and Antidepressant Switching Rate: A Retrospective Cohort Study of Chinese Han Patients
par: Yuhang Yan, et autres
Publié: (2025)

Quantitative Model‐Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation
par: Wangda Zhou, et autres
Publié: (2025)

Population Pharmacokinetic and Exposure–Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis
par: Neha Thakre, et autres
Publié: (2024)

Operationalizing Decentralized Clinical Trials: Technology Insights from the Trials@Home RADIAL Proof‐of‐Concept Trial
par: Sten Hanke, et autres
Publié: (2025)

Bringing Trial Activities to Participants—The Trials@Home RADIAL Proof‐of‐Concept Trial Investigating Decentralization of Trials
par: Mira G.P. Zuidgeest, et autres
Publié: (2025)

Pharmacokinetics and Exposure–Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease
par: Sumit Bhatnagar, et autres
Publié: (2024)

Dose Selection for DuoBody®‐CD40x4‐1BB (GEN1042/BNT312) Using a mPBPK/RO Model Leveraging Preclinical and Clinical Data
par: Gaurav Bajaj, et autres
Publié: (2025)

Changes in S‐Citalopram Plasma Concentrations Across Pregnancy and Postpartum
par: Catherine S. Stika, et autres
Publié: (2025)

Prediction of Acute Liver Injury Trajectory in Patients Following Acetaminophen Overdose: A Multibiomarker Machine Learning Proof‐of‐Concept Study
par: Chris Humphries, et autres
Publié: (2026)

Developing and Refining the Pregnancy Algorithm CErtaInty Tool ( ACE ‐ IT ) for Validating Pregnancy Outcomes
par: Sonal Singh, et autres
Publié: (2025)

Assessment of Dosing Strategies for Pediatric Drug Products
par: Zachary L. Taylor, et autres
Publié: (2024)

Dosing and Exposure of Vancomycin With Continuous Infusion: A Retrospective Study
par: Judith Y. M. N. Derijks‐Engwegen, et autres
Publié: (2024)

Longitudinal Tumor Size and Survival Modeling for Exposure–Response Analysis of Drugs with Frequent Dose Reductions: Dose Justification of Abemaciclib in Patients with Metastatic Breast Cancer
par: Emmanuel Chigutsa, et autres
Publié: (2026)

Viral Kinetics Model of SARS‐CoV‐2 Infection Informs Drug Discovery, Clinical Dose, and Regimen Selection
par: Allison M. Claas, et autres
Publié: (2024)

Optimizing Body Size‐Based Dosing Approaches for Antibody–Drug Conjugates
par: Andrew B. SyBing, et autres
Publié: (2025)

Model‐Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen
par: Peter N. Morcos, et autres
Publié: (2024)

A Phase I, Randomized, Multi‐Dose Study to Evaluate the Enteric Selectivity and Safety of JAK Inhibitor, Lorpucitinib, in Healthy Participants
par: Xuewen Ma, et autres
Publié: (2024)

Model‐Based Patient Selection and Dosing Strategies for HRAS and PIK3CA Dysregulated HNSCC : A QSP Model for Alpelisib and Tipifarnib Combination
par: Jaehee Shim, et autres
Publié: (2026)

Better Rejection‐Free Survival at Three Years in Kidney Transplant Recipients With Model‐Informed Precision Dosing of Mycophenolate Mofetil
par: Claire Villeneuve, et autres
Publié: (2024)

Pathway‐Informed Machine Learning Identifies Genetic Predictors of High‐Dose Methotrexate‐Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia
par: Xiao Yu Cindy Zhang, et autres
Publié: (2025)

Pharmacogenetics of Efavirenz Exposure in Cervicovaginal Fluid during Pregnancy and Postpartum
par: Oluwasegun Eniayewu, et autres
Publié: (2024)

Attaining Equity of Access to Research: Perspective on Research in Pregnancy and Breastfeeding Following Dolores Shockley Lecture at ASCPT2024
par: Catriona Waitt, et autres
Publié: (2024)

Model‐Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations
par: Rashudy F. Mahomedradja, et autres
Publié: (2025)

Correction to Beyond MABEL : An Integrative Approach to First in Human Dose Selection of Immunomodulators by the Health and Environmental Sciences Institute ( HESI ) Immuno‐Safety Technical Committee ( ITC )
Publié: (2024)

Moving the Needle for Oncology Dose Optimization: A Call for Action
par: Karthik Venkatakrishnan, et autres
Publié: (2024)

Dose Optimization Informed by PBPK Modeling: State‐of‐the Art and Future
par: Karen Rowland Yeo, et autres
Publié: (2024)

Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma
par: Ruben Malmberg, et autres
Publié: (2025)

Reply to “On Selection and Analytical Transparency in the FRAME Framework for RWE Evaluation”
par: Gianmario Candore, et autres
Publié: (2026)

Intracellular Penetration of Atazanavir, Ritonavir and Dolutegravir With Concomitant Rifampicin: A Dose Escalation Study
par: Amedeo De Nicolò, et autres
Publié: (2025)

Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment
par: Nikki de Rouw, et autres
Publié: (2025)

Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device Firms
par: Caroline Marra, et autres
Publié: (2024)

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers
par: Mariam A. Ahmed, et autres
Publié: (2024)

Clinical Model‐Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric Patients
par: Zachary L. Taylor, et autres
Publié: (2026)

Safety of Monoclonal Antibodies Inhibiting PCSK9 in Pregnancy: Disproportionality Analysis in VigiBase®
par: Roberta Noseda, et autres
Publié: (2024)

Congenital and Fetal Effects After Mifepristone Exposure and Continuation of Pregnancy: A Systematic Review
par: Joseph V. Turner, et autres
Publié: (2024)

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
par: Mohamed Elmeliegy, et autres
Publié: (2024)